Corbion Ends PLA Sale as Ingredient Volumes Lift Quarterly Profit 29%
Corbion has stopped trying to sell its stake in the TotalEnergies Corbion bioplastics venture after rejecting offers it considered too low, just as stronger ingredient volumes helped lift third-quarter adjusted EBITDA by 29%.
The two developments connect food ingredients and packaging strategy. Corbion's fermentation and preservation businesses generated a sharp quarterly rebound, while the retained joint venture keeps the company exposed to polylactic acid, or PLA, used in compostable and bio-based packaging.
The Amsterdam-listed company announced the decision with its third-quarter results on 28 October 2026. Quarterly sales reached €340.5 million, up 9.3% as reported and 7.6% organically.
Growth came from volume and mix, not higher prices
Corbion said third-quarter volume and product mix improved 7.9%, while pricing reduced organic growth by 0.3%. That composition matters to food manufacturers because it suggests the sales gain was driven primarily by more or higher-value products moving through the business, rather than broad price increases passed to customers.
Demand for natural food-preservation solutions remained healthy. Health & Nutrition grew particularly strongly, although the company said some nutrition volume had shifted from the first half into the third quarter. Higher fish-oil prices also lifted omega-3 DHA pricing and improved the reported mix.
Measure | Q3 2026 | Q3 2025 | Change |
Sales | €340.5m | €311.6m | +9.3% reported |
Organic sales growth | +7.6% | Not applicable | Volume/mix +7.9%; price -0.3% |
Adjusted EBITDA | €64.1m | €49.7m | +29.0% |
Adjusted EBITDA margin | 18.8% | 15.9% | +2.9 percentage points |
Operating profit | €39.3m | €27.9m | +40.9% |
Adjusted EBITDA reached €64.1 million from €49.7 million, and the margin expanded by 2.9 percentage points to 18.8%. Corbion credited cost reductions, operating efficiency and the favorable omega-3 pricing effect as well as volume growth.
One strong quarter does not erase the weaker first half
The nine-month picture is more restrained. Sales rose only 1.5% as reported to €971.6 million, although organic growth was 3.9%. Adjusted EBITDA fell 2.2% to €152.9 million and the nine-month margin narrowed from 16.3% to 15.7%.
That difference reflects a weak start to the year followed by improvement in the second and third quarters. It also shows why the 18.8% quarterly margin should not automatically be treated as the new annual run rate. Product timing, fish-oil prices and customer orders can move results between quarters.
Free cash flow reached €57 million for the first nine months. Corbion maintained its full-year guidance for 3% to 6% organic sales growth, an adjusted EBITDA margin above 16%, and €85 million to €90 million of free cash flow.
Corbion keeps the PLA stake because bids fell short
Corbion had been exploring a sale of its interest in the TotalEnergies Corbion joint venture. The process attracted buyers, but management said their proposals did not reflect the asset's value, strategic position or long-term potential.
Ending the sale process means Corbion retains both the opportunity and the execution risk. PLA can serve packaging customers seeking bio-based materials, but commercial outcomes depend on resin demand, plant utilization, energy and feedstock costs, competing polymers, waste infrastructure and the rules governing compostability claims.
The decision should therefore not be interpreted as proof that the venture is worth more than the bids. It shows only that Corbion believes continuing to develop the asset offers a better risk-adjusted path than accepting the offers received.
Why food and packaging companies should care
Food manufacturers face two linked procurement questions. The first is whether preservation and nutrition ingredients remain available at competitive prices as input costs move. The second is whether packaging suppliers can scale lower-carbon materials without sacrificing barrier performance, machinability or cost.
Corbion sits across both questions. Its food business supplies preservation solutions that can support shelf life, while its PLA exposure links fermentation-derived feedstocks to packaging. Retaining the joint venture keeps those activities strategically connected, even though they have different customers and profit drivers.
The volume-led nature of the third-quarter growth is encouraging for underlying demand. The negative pricing contribution, however, means revenue is not being protected by inflation alone. If volume normalizes after the timing benefit in Nutrition, cost control and product mix will have to do more of the work.
What to watch next
The fourth-quarter order book supports management's maintained guidance, but three indicators deserve attention: whether Health & Nutrition volumes remain strong after the timing effect fades, whether the group margin stays above 16% for the year, and what investment or operating plan Corbion sets for the retained PLA stake.
Customers should also watch the balance between ingredient pricing and fish-oil costs. Higher omega-3 prices improved Corbion's mix in the quarter, but they can also affect downstream formulation costs for aquaculture, supplements and specialized nutrition.
Related Agrilinkage analysis: SIG's higher profit outlook and €250 million packaging impairment shows how quickly packaging demand, asset values and segment performance can diverge.
Methodology: Agrilinkage compared Corbion's reported third-quarter and nine-month figures and separated reported growth, organic growth, volume and price effects. The company defines adjusted EBITDA and organic growth as non-GAAP performance measures.
Comments